These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30355952)

  • 1. 2-O-Methylmagnolol Induces Apoptosis and Inhibits IL-6/STAT3 Signaling in Oral Squamous Cell Carcinoma.
    Wang TH; Fang JY; Wu SJ; Liu YW; Chan CW; Chuang SY; Chen CY
    Cell Physiol Biochem; 2018; 50(3):883-892. PubMed ID: 30355952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of Histone Deacetylase Inhibitor Sensitivity in Combination with Cyclin-Dependent Kinase Inhibition for the Treatment of Oral Squamous Cell Carcinoma.
    Zhao B; Huang Z; Qin Z; Li Y; Wang T; Wang L; Zhou W; Yu C; Wang X; Yang S; Fan Y; Xiang R
    Cell Physiol Biochem; 2019; 53(1):141-156. PubMed ID: 31237760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnolol's Therapeutic Efficacy and Immunomodulatory Effects in Oral Squamous Cell Carcinoma.
    Tseng CF; Chen HM; Liao TL; Hsu FT; Yeh CJ; Chen WT; Kok SH
    In Vivo; 2024; 38(5):2152-2164. PubMed ID: 39187336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect of honokiol and 5-fluorouracil on apoptosis of oral squamous cell carcinoma cells.
    Ji N; Jiang L; Deng P; Xu H; Chen F; Liu J; Li J; Liao G; Zeng X; Lin Y; Feng M; Li L; Chen Q
    J Oral Pathol Med; 2017 Mar; 46(3):201-207. PubMed ID: 27465776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Icaritin Reduces Oral Squamous Cell Carcinoma Progression via the Inhibition of STAT3 Signaling.
    Yang JG; Lu R; Ye XJ; Zhang J; Tan YQ; Zhou G
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
    Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
    J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnolol Inhibits the Growth of Non-Small Cell Lung Cancer via Inhibiting Microtubule Polymerization.
    Shen J; Ma H; Zhang T; Liu H; Yu L; Li G; Li H; Hu M
    Cell Physiol Biochem; 2017; 42(5):1789-1801. PubMed ID: 28746938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of cell cycle and let-7a/STAT3 pathway by niclosamide inhibits proliferation, migration and invasion in oral squamous cell carcinoma cells.
    Li X; Ding R; Han Z; Ma Z; Wang Y
    Biomed Pharmacother; 2017 Dec; 96():434-442. PubMed ID: 29031202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
    Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.
    Liu R; Peng J; Wang H; Li L; Wen X; Tan Y; Zhang L; Wan H; Chen F; Nie X
    Cell Physiol Biochem; 2018; 49(5):1717-1733. PubMed ID: 30231242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnolol inhibits cancer stemness and IL-6/Stat3 signaling in oral carcinomas.
    Peng CY; Yu CC; Huang CC; Liao YW; Hsieh PL; Chu PM; Yu CH; Lin SS
    J Formos Med Assoc; 2022 Jan; 121(1 Pt 1):51-57. PubMed ID: 33551310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
    Tang H; Zhang Y; Li D; Fu S; Tang M; Wan L; Chen K; Liu Z; Xue L; Peng A; Ye H; Chen L
    Eur J Med Chem; 2018 Aug; 156():190-205. PubMed ID: 30006164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemosensitizing effect of honokiol in oral carcinoma stem cells via regulation of IL-6/Stat3 signaling.
    Chang MT; Lee SP; Fang CY; Hsieh PL; Liao YW; Lu MY; Tsai LL; Yu CC; Liu CM
    Environ Toxicol; 2018 Nov; 33(11):1105-1112. PubMed ID: 30076764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kochia scoparia induces apoptosis of oral cancer cells in vitro and in heterotopic tumors.
    Han HY; Lee HE; Kim HJ; Jeong SH; Kim JH; Kim H; Ryu MH
    J Ethnopharmacol; 2016 Nov; 192():431-441. PubMed ID: 27616033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3 inhibitor WP1066 attenuates miRNA-21 to suppress human oral squamous cell carcinoma growth in vitro and in vivo.
    Zhou X; Ren Y; Liu A; Han L; Zhang K; Li S; Li P; Li P; Kang C; Wang X; Zhang L
    Oncol Rep; 2014 May; 31(5):2173-80. PubMed ID: 24676554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of magnolol on UVB-induced skin cancer development in mice and its possible mechanism of action.
    Chilampalli C; Guillermo R; Zhang X; Kaushik RS; Young A; Zeman D; Hildreth MB; Fahmy H; Dwivedi C
    BMC Cancer; 2011 Oct; 11():456. PubMed ID: 22014088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alkannin restrains oral squamous carcinoma cell growth, migration and invasion by regulating microRNA-9/RECK axis.
    Mao Y; Zhang W; Zhang R; Zuo J
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3153-3162. PubMed ID: 31349748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arglabin is a plant sesquiterpene lactone that exerts potent anticancer effects on human oral squamous cancer cells via mitochondrial apoptosis and downregulation of the mTOR/PI3K/Akt signaling pathway to inhibit tumor growth in vivo.
    He W; Lai R; Lin Q; Huang Y; Wang L
    J BUON; 2018; 23(6):1679-1685. PubMed ID: 30610794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin‑3 blockade suppresses the growth of cetuximab‑resistant human oral squamous cell carcinoma.
    Yin P; Cui S; Liao X; Yao X
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34328195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnolol suppresses the proliferation and invasion of cholangiocarcinoma cells via inhibiting the NF-κB signaling pathway.
    Zhang FH; Ren HY; Shen JX; Zhang XY; Ye HM; Shen DY
    Biomed Pharmacother; 2017 Oct; 94():474-480. PubMed ID: 28779709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.